Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “control”

270 pharma patents match "control" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 270
Index total 30,257
Page 9 / 12

Quick answer

This filtered view shows 270 pharmaceutical patents matching "control" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

270 results for “control” · 30,257 patents in full index Clear search

  1. US 8197823

    Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof

    China Animal Disease Control Center · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

  2. US 8193211

    Controlled release compositions of gamma-hydroxybutyrate

    Supernus Pharmaceuticals, Inc. · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  3. US 8187708

    Microphasic micro-components and methods for controlling morphology via electrified jetting

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 29, 2012 · Expires May 24, 2032

    granted

  4. US 8163545

    Vaccine against pandemic strains of influenza viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  5. US 8125225

    Transmit profile control in MRI

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  6. US 8110554

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  7. US 8111019

    Sensing type control circuit for electronic apparatus

    Princeton Technology Corporation · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  8. US 8105609

    Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  9. US 8088365

    Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  10. US 8071545

    Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism

    Lewis S. Coleman, MD, Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  11. US 8067030

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  12. US 8030297

    Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

    The Regents of the University of California · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  13. US 8025887

    Avirulent, immunogenic flavivirus chimeras

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 27, 2011 · Expires Sep 22, 2031

    granted

  14. US 7985401

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Jul 26, 2011 · Expires Jul 21, 2031

    granted

  15. US 7972661

    Electrospraying method with conductivity control

    Regents of the University of Minnesota · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  16. US 7964217

    Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

    Nektar Therapeutics · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  17. US 7959929

    Materials and methods for respiratory disease control in canines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  18. US 7919104

    Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  19. US 7906292

    Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  20. US 7863041

    Rabies virus vector systems and compositions and methods thereof

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  21. US 2010331426

    Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria

    AIR LIQUIDE SANTE INT [FR] · Granted Dec 30, 2010 · Expires Dec 25, 2030

    granted

  22. US 7790755

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  23. US 7776521

    Coronavirus isolated from humans

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  24. US 7674480

    Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.